Literature DB >> 11336914

Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats.

G Schmidmaier1, B Wildemann, H Bail, M Lucke, T Fuchs, A Stemberger, A Flyvbjerg, N P Haas, M Raschke.   

Abstract

In vitro and in vivo studies have demonstrated an osteoinductive effect of growth factors such as insulin-like growth factor-1 (IGF-1) and transforming growth factor-beta1 (TGF-beta1). However, for therapeutic use in fracture treatment, questions remain with regard to the local application of these proteins. A controlled, local release of growth factors from a biodegradable polylactide coating of osteosynthetic implants may have a stimulating effect on fracture healing. Such implants could stabilize the fracture and their bioactive surface could function simultaneously as a local drug-delivery system. Previous studies have demonstrated the high mechanical stability of an approximately 10-14-microm-thick poly(D,L-lactide) (PDLLA) coating on metallic implants, which can even withstand the process of intramedullary insertion. Following an initial peak, 80% of incorporated growth factors IGF-1 and TGF-beta1 were continuously released within 42 days. The effect of locally applied IGF-1 and TGF-beta1 from a biodegradable PDLLA coating of intramedullary implants on fracture healing was investigated in a rat model. Midshaft fractures of the right tibia of 5-month-old female Sprague-Dawley rats (n = 127) were stabilized with coated vs. uncoated titanium Kirschner wires. X-ray examinations and blood analyses were performed, and body weight and body temperature measurements were taken throughout the experimental period. After 28 and 42 days, respectively, tibiae were dissected for mechanical torsional testing and histomorphometrical analyses. X-rays demonstrated an almost completely consolidated fracture, biomechanical testing showed a significantly higher maximum load and torsional stiffness, and histological and histomorphometric analyses demonstrated progressed remodeling after 28 and 42 days in the group treated with growth factors as compared with controls. Interestingly, the PDLLA coating itself revealed a positive effect on fracture healing even without incorporated growth factors. No systemic changes of serum parameters, including IGF-1 and IGF binding proteins, and no differences in body weight and body temperature were observed within and between groups. These findings suggest that the local application of growth factors from a biodegradable PDLLA coating of osteosynthetic implants accelerates fracture healing significantly without systemic side effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336914     DOI: 10.1016/s8756-3282(00)00456-7

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  29 in total

1.  Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model.

Authors:  F Kandziora; R Pflugmacher; M Scholz; J Schäfer; G Schollmeier; G Schmidmaier; G Duda; M Raschke; N P Haas
Journal:  Eur Spine J       Date:  2002-11-08       Impact factor: 3.134

Review 2.  Surface treatments and roughness properties of Ti-based biomaterials.

Authors:  Andrea Bagno; Carlo Di Bello
Journal:  J Mater Sci Mater Med       Date:  2004-09       Impact factor: 3.896

Review 3.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

4.  Effects of systemic and local administration of recombinant human IGF-I (rhIGF-I) on de novo bone formation in an aged mouse model.

Authors:  John L Fowlkes; Kathryn M Thrailkill; Lichu Liu; Elizabeth C Wahl; Robert C Bunn; Gael E Cockrell; Daniel S Perrien; James Aronson; Charles K Lumpkin
Journal:  J Bone Miner Res       Date:  2006-09       Impact factor: 6.741

5.  Novel nanocomposite coating for dental implant applications in vitro and in vivo evaluation.

Authors:  M Mehdikhani-Nahrkhalaji; M H Fathi; V Mortazavi; S B Mousavi; B Hashemi-Beni; S M Razavi
Journal:  J Mater Sci Mater Med       Date:  2011-11-30       Impact factor: 3.896

Review 6.  How does the pathophysiological context influence delivery of bone growth factors?

Authors:  Xiaohua Yu; Darilis Suárez-González; Andrew S Khalil; William L Murphy
Journal:  Adv Drug Deliv Rev       Date:  2014-10-17       Impact factor: 15.470

7.  Combined use of low-intensity pulsed ultrasound and rhBMP-2 to enhance bone formation in a rat model of critical size defect.

Authors:  Siddhesh R Angle; Kotaro Sena; Dale R Sumner; Walter W Virkus; Amarjit S Virdi
Journal:  J Orthop Trauma       Date:  2014-10       Impact factor: 2.512

8.  Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis. A new fracture-healing model at the tibia in rat.

Authors:  E K Stuermer; S Sehmisch; T Rack; E Wenda; D Seidlova-Wuttke; M Tezval; W Wuttke; K H Frosch; K M Stuermer
Journal:  Langenbecks Arch Surg       Date:  2008-12-02       Impact factor: 3.445

9.  Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?

Authors:  Leila Kolios; Ann Kristin Hoerster; Stephan Sehmisch; Marie Christin Malcherek; Thomas Rack; Mohammed Tezval; Dana Seidlova-Wuttke; Wolfgang Wuttke; Klaus Michael Stuermer; Ewa Klara Stuermer
Journal:  Calcif Tissue Int       Date:  2009-12-01       Impact factor: 4.333

10.  Effect of local TGF-beta1 and IGF-1 release on implant fixation: comparison with hydroxyapatite coating: a paired study in dogs.

Authors:  Anders Lamberg; Joan E Bechtold; Jørgen Baas; Kjeld Søballe; Brian Elmengaard
Journal:  Acta Orthop       Date:  2009-08       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.